Logo image of DDD.CA

METAVISTA 3D INC (DDD.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:DDD - CA59142H1073 - Common Stock

1.01 CAD
+0.06 (+6.32%)
Last: 1/22/2026, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, DDD scores 2 out of 10 in our fundamental rating. DDD was compared to 15 industry peers in the Electronic Equipment, Instruments & Components industry. While DDD seems to be doing ok healthwise, there are quite some concerns on its profitability. DDD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • DDD had negative earnings in the past year.
  • DDD had a negative operating cash flow in the past year.
DDD.CA Yearly Net Income VS EBIT VS OCF VS FCFDDD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -571.77%, DDD is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
  • DDD has a Return On Equity of -750.51%. This is in the lower half of the industry: DDD underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -571.77%
ROE -750.51%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DDD.CA Yearly ROA, ROE, ROICDDD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DDD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DDD.CA Yearly Profit, Operating, Gross MarginsDDD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for DDD remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for DDD has been reduced compared to a year ago.
DDD.CA Yearly Shares OutstandingDDD.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
DDD.CA Yearly Total Debt VS Total AssetsDDD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

  • An Altman-Z score of 49.15 indicates that DDD is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 49.15, DDD belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.13 indicates that DDD is not too dependend on debt financing.
  • DDD has a Debt to Equity ratio of 0.13. This is in the better half of the industry: DDD outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 49.15
ROIC/WACCN/A
WACCN/A
DDD.CA Yearly LT Debt VS Equity VS FCFDDD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M 2M 3M

2.3 Liquidity

  • DDD has a Current Ratio of 4.20. This indicates that DDD is financially healthy and has no problem in meeting its short term obligations.
  • DDD has a better Current ratio (4.20) than 80.00% of its industry peers.
  • A Quick Ratio of 4.20 indicates that DDD has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 4.20, DDD is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.2
Quick Ratio 4.2
DDD.CA Yearly Current Assets VS Current LiabilitesDDD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

  • DDD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1684.72%.
EPS 1Y (TTM)-1684.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-389.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DDD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DDD.CA Price Earnings VS Forward Price EarningsDDD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DDD.CA Per share dataDDD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for DDD!.
Industry RankSector Rank
Dividend Yield 0%

METAVISTA 3D INC

TSX-V:DDD (1/22/2026, 7:00:00 PM)

1.01

+0.06 (+6.32%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-29
Earnings (Next)04-20
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.61%
Ins Owner ChangeN/A
Market Cap114.95M
Revenue(TTM)1.81M
Net Income(TTM)-28.95M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 63.52
P/FCF N/A
P/OCF N/A
P/B 29.8
P/tB 29.8
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.02
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -571.77%
ROE -750.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.2
Quick Ratio 4.2
Altman-Z 49.15
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1684.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-389.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-727.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-603.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-603.96%
OCF growth 3YN/A
OCF growth 5YN/A

METAVISTA 3D INC / DDD.CA FAQ

Can you provide the ChartMill fundamental rating for METAVISTA 3D INC?

ChartMill assigns a fundamental rating of 2 / 10 to DDD.CA.


What is the valuation status for DDD stock?

ChartMill assigns a valuation rating of 0 / 10 to METAVISTA 3D INC (DDD.CA). This can be considered as Overvalued.


Can you provide the profitability details for METAVISTA 3D INC?

METAVISTA 3D INC (DDD.CA) has a profitability rating of 0 / 10.


What is the financial health of METAVISTA 3D INC (DDD.CA) stock?

The financial health rating of METAVISTA 3D INC (DDD.CA) is 6 / 10.